Cargando…
A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700333/ https://www.ncbi.nlm.nih.gov/pubmed/34977828 http://dx.doi.org/10.1016/S2666-5247(21)00331-1 |
| _version_ | 1784620731710046208 |
|---|---|
| author | Zhang, Rong Li, Dedong Xu, Kun Yang, Chenxi Luo, Tingrong Zhao, Xin Gao, George F |
| author_facet | Zhang, Rong Li, Dedong Xu, Kun Yang, Chenxi Luo, Tingrong Zhao, Xin Gao, George F |
| author_sort | Zhang, Rong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8700333 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Author(s). Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87003332021-12-28 A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice Zhang, Rong Li, Dedong Xu, Kun Yang, Chenxi Luo, Tingrong Zhao, Xin Gao, George F Lancet Microbe Correspondence The Author(s). Published by Elsevier Ltd. 2022-03 2021-12-23 /pmc/articles/PMC8700333/ /pubmed/34977828 http://dx.doi.org/10.1016/S2666-5247(21)00331-1 Text en © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Zhang, Rong Li, Dedong Xu, Kun Yang, Chenxi Luo, Tingrong Zhao, Xin Gao, George F A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice |
| title | A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice |
| title_full | A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice |
| title_fullStr | A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice |
| title_full_unstemmed | A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice |
| title_short | A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice |
| title_sort | protein subunit vaccine booster following two doses of inactivated sars-cov-2 vaccine provides high neutralisation of sars-cov-2 and its variants in mice |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700333/ https://www.ncbi.nlm.nih.gov/pubmed/34977828 http://dx.doi.org/10.1016/S2666-5247(21)00331-1 |
| work_keys_str_mv | AT zhangrong aproteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT lidedong aproteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT xukun aproteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT yangchenxi aproteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT luotingrong aproteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT zhaoxin aproteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT gaogeorgef aproteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT zhangrong proteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT lidedong proteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT xukun proteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT yangchenxi proteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT luotingrong proteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT zhaoxin proteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice AT gaogeorgef proteinsubunitvaccineboosterfollowingtwodosesofinactivatedsarscov2vaccineprovideshighneutralisationofsarscov2anditsvariantsinmice |